AMAG slips on potential Feraheme signal

AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) fell $3.53 (15%) to $19.96 on Tuesday after canceling a Sept. 22 presentation at the UBS Global Life Sciences Conference due to an upcoming meeting with FDA to ...